Clinical Trial Update: 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

View source ↗

Summary

This clinical trial update describes the use of the PET imaging agent 18F-fluorothymidine (18F-FLT) in cancer patients to assess tumor proliferation, and the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumors
• Leukemia
• Lymphoma
• Lymphoproliferative Disorders
• Multiple Myeloma
• Myelodysplastic Myeloproliferative Neoplasms
• Myelodysplastic Syndromes
• Myeloproliferative Neoplasms

Drugs mentioned

• 18F-fluorothymidine (18F-FLT) PET imaging agent (18F-fluorothymidine)

Snippet

Sponsor: Barbara Ann Karmanos Cancer Institute | Conditions: Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders | Status: RECRUITING